Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in Platinum/Taxane-Refractory Ovarian Cancer
NCT00097409Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ispinesib in ovarian cancer, sponsored by GSK. Started Dec 2004; status: completed.
02
Drugs
ispinesib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00097409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097409.